Literature DB >> 33313059

Leveraging Data Science for a Personalized Haemodialysis.

Miguel Hueso1, Lluís de Haro2, Jordi Calabia3, Rafael Dal-Ré4, Cristian Tebé5, Karina Gibert6, Josep M Cruzado1, Alfredo Vellido6.   

Abstract

BACKGROUND: The 2019 Science for Dialysis Meeting at Bellvitge University Hospital was devoted to the challenges and opportunities posed by the use of data science to facilitate precision and personalized medicine in nephrology, and to describe new approaches and technologies. The meeting included separate sections for issues in data collection and data analysis. As part of data collection, we presented the institutional ARGOS e-health project, which provides a common model for the standardization of clinical practice. We also pay specific attention to the way in which randomized controlled trials offer data that may be critical to decision-making in the real world. The opportunities of open source software (OSS) for data science in clinical practice were also discussed.
SUMMARY: Precision medicine aims to provide the right treatment for the right patients at the right time and is deeply connected to data science. Dialysis patients are highly dependent on technology to live, and their treatment generates a huge volume of data that has to be analysed. Data science has emerged as a tool to provide an integrated approach to data collection, storage, cleaning, processing, analysis, and interpretation from potentially large volumes of information. This is meant to be a perspective article about data science based on the experience of the experts invited to the Science for Dialysis Meeting and provides an up-to-date perspective of the potential of data science in kidney disease and dialysis. KEY MESSAGES: Healthcare is quickly becoming data-dependent, and data science is a discipline that holds the promise of contributing to the development of personalized medicine, although nephrology still lags behind in this process. The key idea is to ensure that data will guide medical decisions based on individual patient characteristics rather than on averages over a whole population usually based on randomized controlled trials that excluded kidney disease patients. Furthermore, there is increasing interest in obtaining data about the effectiveness of available treatments in current patient care based on pragmatic clinical trials. The use of data science in this context is becoming increasingly feasible in part thanks to the swift developments in OSS.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Artificial intelligence; Data science; Haemodialysis; Machine learning; Personalized medicine; Pragmatic clinical trials

Year:  2020        PMID: 33313059      PMCID: PMC7706504          DOI: 10.1159/000507291

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  34 in total

1.  eHealth interventions for people with chronic kidney disease.

Authors:  Jessica K Stevenson; Zoe C Campbell; Angela C Webster; Clara K Chow; Allison Tong; Jonathan C Craig; Katrina L Campbell; Vincent Ws Lee
Journal:  Cochrane Database Syst Rev       Date:  2019-08-06

2.  Artificial Intelligence in Nephrology: Core Concepts, Clinical Applications, and Perspectives.

Authors:  Olivier Niel; Paul Bastard
Journal:  Am J Kidney Dis       Date:  2019-08-23       Impact factor: 8.860

3.  An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients.

Authors:  Carlo Barbieri; Manuel Molina; Pedro Ponce; Monika Tothova; Isabella Cattinelli; Jasmine Ion Titapiccolo; Flavio Mari; Claudia Amato; Frank Leipold; Wolfgang Wehmeyer; Stefano Stuard; Andrea Stopper; Bernard Canaud
Journal:  Kidney Int       Date:  2016-06-02       Impact factor: 10.612

4.  Impact of hemocontrol on hypertension, nursing interventions, and quality of life: a randomized, controlled trial.

Authors:  Clément Déziel; Josée Bouchard; Michael Zellweger; François Madore
Journal:  Clin J Am Soc Nephrol       Date:  2007-04-25       Impact factor: 8.237

Review 5.  Development of an Artificial Intelligence Model to Guide the Management of Blood Pressure, Fluid Volume, and Dialysis Dose in End-Stage Kidney Disease Patients: Proof of Concept and First Clinical Assessment.

Authors:  Carlo Barbieri; Isabella Cattinelli; Luca Neri; Flavio Mari; Rosa Ramos; Diego Brancaccio; Bernard Canaud; Stefano Stuard
Journal:  Kidney Dis (Basel)       Date:  2018-11-07

Review 6.  Societal Issues Concerning the Application of Artificial Intelligence in Medicine.

Authors:  Alfredo Vellido
Journal:  Kidney Dis (Basel)       Date:  2018-09-03

7.  CDKD: a clinical database of kidney diseases.

Authors:  Sanjay Kr Singh; Adeel Malik; Ahmad Firoz; Vivekanand Jha
Journal:  BMC Nephrol       Date:  2012-04-27       Impact factor: 2.388

Review 8.  Utilization of open source electronic health record around the world: A systematic review.

Authors:  Farzaneh Aminpour; Farahnaz Sadoughi; Maryam Ahamdi
Journal:  J Res Med Sci       Date:  2014-01       Impact factor: 1.852

Review 9.  Free/Libre open source software in health care: a review.

Authors:  Thomas Karopka; Holger Schmuhl; Hans Demski
Journal:  Healthc Inform Res       Date:  2014-01-31

10.  Enabling Psychiatrists to be Mobile Phone App Developers: Insights Into App Development Methodologies.

Authors:  Melvyn Wb Zhang; Tammy Tsang; Enquan Cheow; Cyrus Sh Ho; Ng Beng Yeong; Roger Cm Ho
Journal:  JMIR Mhealth Uhealth       Date:  2014-11-11       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.